Literature DB >> 17206459

A comparison of myocardial perfusion and rejection in cardiac transplant patients.

Andrew L Rivard1, Cory M Swingen, Donnevan Blake, Andrea S Huang, Pooja Kanth, Grete F Thomsen, Erin J Cordova, Leslie W Miller, Richard W Bianco, Norbert Wilke.   

Abstract

INTRODUCTION: Although histological evaluation of the cardiac tissue is the current gold standard for evaluation of rejection, we hypothesized that cardiac perfusion MRI is a safe non-invasive method that correlates tissue blood flow changes with biopsy proven rejection in the cardiac transplant patient.
MATERIALS AND METHODS: In a retrospective study from 1984-2001, 83 patients underwent 135 MR Gd-DTPA imaging studies. In 8 patients (9%), biopsies graded 2 or higher (by ISHLT criteria) provided evidence of rejection. Patients were age and sex matched to 11 non-rejected controls for imaging analysis. Time-signal intensity curves generated for a mid-ventricle LV short axis slice during rest and adenosine stress allowed determination of myocardial blood flow (MBF, ml/min/gm). ROC curve analysis by SPSS allowed estimation of sensitivity and specificity.
RESULTS: At rest, there was no difference in MBF between patients with prior rejection vs. those without (1.18 +/- 0.26 vs. 1.16 +/- 0.29). At stress there was a decrease in MBF for patients with prior rejection episodes (3.27 +/- 0.74) compared to no rejection (3.60 +/- 0.72), P = 0.067). The area under the ROC curve was 0.82, with specificity and sensitivity of 75% and 81%, respectively.
CONCLUSION: This study suggests that perfusion MR imaging can be used in assessing the cardiac transplant patient for rejection related microvascular changes. The high specificity and sensitivity recorded from the ROC curve illustrates the potential utility of this diagnostic test for future studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17206459     DOI: 10.1007/s10554-006-9184-6

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  31 in total

1.  Assessment of cardiac rejection by MR-imaging and MR-spectroscopy.

Authors:  B H Walpoth; M F Müller; B Celik; B Nicolaus; N Walpoth; T Schaffner; U Althaus; T Carrel
Journal:  Eur J Cardiothorac Surg       Date:  1998-10       Impact factor: 4.191

2.  Modeling regional myocardial flows from residue functions of an intravascular indicator.

Authors:  K Kroll; N Wilke; M Jerosch-Herold; Y Wang; Y Zhang; R J Bache; J B Bassingthwaighte
Journal:  Am J Physiol       Date:  1996-10

3.  Cardiac allograft vascular disease. Relationship to microvascular cell surface markers and inflammatory cell phenotypes on endomyocardial biopsy.

Authors:  M C Deng; S Bell; P Huie; F Pinto; S A Hunt; E B Stinson; R Sibley; B M Hall; H A Valantine
Journal:  Circulation       Date:  1995-03-15       Impact factor: 29.690

4.  An analysis of repeated biopsies following cardiac transplantation.

Authors:  D J Spiegelhalter; P G Stovin
Journal:  Stat Med       Date:  1983 Jan-Mar       Impact factor: 2.373

5.  The economic implications of noninvasive molecular testing for cardiac allograft rejection.

Authors:  Roger W Evans; Gavin E Williams; Helen M Baron; Mario C Deng; Howard J Eisen; Sharon A Hunt; Mahmud M Khan; Jon A Kobashigawa; Eric N Marton; Mandeep R Mehra; Seema R Mital
Journal:  Am J Transplant       Date:  2005-06       Impact factor: 8.086

6.  Early phosphorus 31 nuclear magnetic resonance bioenergetic changes potentially predict rejection in heterotopic cardiac allografts.

Authors:  C D Fraser; V P Chacko; W E Jacobus; P Mueller; R L Soulen; G M Hutchins; B A Reitz; W A Baumgartner
Journal:  J Heart Transplant       Date:  1990 May-Jun

7.  Diagnostic applicability of magnetic resonance imaging in assessing human cardiac allograft rejection.

Authors:  G Wisenberg; P W Pflugfelder; W J Kostuk; F N McKenzie; F S Prato
Journal:  Am J Cardiol       Date:  1987-07-01       Impact factor: 2.778

8.  Magnetic resonance imaging of cardiac transplants: the evaluation of rejection of cardiac allografts with and without immunosuppression.

Authors:  T Aherne; D Tscholakoff; W Finkbeiner; U Sechtem; N Derugin; E Yee; C B Higgins
Journal:  Circulation       Date:  1986-07       Impact factor: 29.690

9.  Reduced myocardial perfusion reserve and transmural perfusion gradient in heart transplant arteriopathy assessed by magnetic resonance imaging.

Authors:  Olaf M Muehling; Norbert M Wilke; Prasad Panse; Michael Jerosch-Herold; Betsy V Wilson; Robert F Wilson; Leslie W Miller
Journal:  J Am Coll Cardiol       Date:  2003-09-17       Impact factor: 24.094

10.  Role of interleukin 2 receptors in immunologic monitoring following cardiac transplantation.

Authors:  S T Roodman; L W Miller; C C Tsai
Journal:  Transplantation       Date:  1988-06       Impact factor: 4.939

View more
  5 in total

1.  Cellular and Functional Imaging of Cardiac Transplant Rejection.

Authors:  Yijen L Wu; Qing Ye; Chien Ho
Journal:  Curr Cardiovasc Imaging Rep       Date:  2011-02-01

2.  Allograft coronary artery thrombosis: a case report of early cardiac allograft left ventricular myocardial infarction.

Authors:  Sergio A Torres; Omar Cheema; Dipan J Shah; Guillermo Torre-Amione; Jerry D Estep
Journal:  Methodist Debakey Cardiovasc J       Date:  2012-01

3.  Comprehensive morphologic and functional imaging of heart transplant patients: first experience with dynamic perfusion CT.

Authors:  S Oebel; S Hamada; K Higashigaito; J von Spiczak; E Klotz; F Enseleit; R Hinzpeter; F Ruschitzka; R Manka; H Alkadhi
Journal:  Eur Radiol       Date:  2018-04-30       Impact factor: 5.315

4.  Speckle-tracking 2-dimensional strain echocardiography: a new noninvasive imaging tool to evaluate acute rejection in cardiac transplantation.

Authors:  Galen M Pieper; Akash Shah; Leanne Harmann; Brian C Cooley; Irina A Ionova; Raymond Q Migrino
Journal:  J Heart Lung Transplant       Date:  2010-05-20       Impact factor: 13.569

Review 5.  Quantification in cardiac MRI: advances in image acquisition and processing.

Authors:  Anil K Attili; Andreas Schuster; Eike Nagel; Johan H C Reiber; Rob J van der Geest
Journal:  Int J Cardiovasc Imaging       Date:  2010-02       Impact factor: 2.357

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.